0001209191-18-045430.txt : 20180803
0001209191-18-045430.hdr.sgml : 20180803
20180803191636
ACCESSION NUMBER: 0001209191-18-045430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180801
FILED AS OF DATE: 20180803
DATE AS OF CHANGE: 20180803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Laura K
CENTRAL INDEX KEY: 0001402605
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33876
FILM NUMBER: 18993207
MAIL ADDRESS:
STREET 1: 3201 CARNEGIE AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATHERSYS, INC / NEW
CENTRAL INDEX KEY: 0001368148
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 204864095
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3201 CARNEGIE AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115-2634
BUSINESS PHONE: 216-431-9900
MAIL ADDRESS:
STREET 1: 3201 CARNEGIE AVENUE
CITY: CLEVELAND
STATE: OH
ZIP: 44115-2634
FORMER COMPANY:
FORMER CONFORMED NAME: BTHC VI Inc
DATE OF NAME CHANGE: 20060629
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-01
0
0001368148
ATHERSYS, INC / NEW
ATHX
0001402605
Campbell Laura K
3201 CARNEGIE AVENUE
CLEVELAND
OH
44115-2634
0
1
0
0
Senior Vice Pres Finance
Common Stock
2018-08-01
4
S
0
4700
2.0048
D
602944
D
Common Stock
2018-08-02
4
S
0
9720
2.0052
D
593224
D
Shares sold pursuant to a Rule 10b5-1 trading plan that commenced in July 2018. A predefined number of shares may be sold from time-to-time based on predefined price increases over a two-year period.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.02, inclusive.
Securities beneficially owned are comprised of: (1) 436,272 shares of common stock owned and (2) unvested restricted stock units aggregating 156,952 related to annual awards, which vest quarterly over a three or four-year period from grant date.
/s/ Laura K. Campbell
2018-08-03